drugset / Trial / NCT05097716
Study to Evaluate the Effect of Multiple-Dose Ritlecitinib on the Pharmacokinetics (PK) of Tolbutamide
NaSequentialOpen-labelBasic science
Summary
This is a Phase 1, 2-period, multiple-dose, open-label, single fixed sequence study of the effect of ritlecitinib on tolbutamide pharmacokinetics in healthy participants.
Timeline
- Start
- 2021-11-02
- Primary completion
- 2022-01-10
- Completion
- 2022-01-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ritlecitinib | Small molecule | 200 mg | Oral |
| Subject | Tolbutamide | Small molecule | 500 mg | Oral |
Indications
No indication recorded.